PerkinElmer

PerkinElmer
Name	PerkinElmer
Type	Public
Industry	Biotechnology; Diagnostics; Life sciences; Instrumentation
Founded	1937
Founder	Richard Perkin; Charles Elmer
Headquarters	Waltham, Massachusetts, United States
Area served	Global
Products	Analytical instruments; Diagnostic assays; Imaging systems; Genomics solutions; Laboratory services
Key people	Prahlad Singh (President & CEO); [Chair]
Revenue	(varies by year)
Num employees	(approximate)

PerkinElmer is a multinational corporation specializing in scientific instrumentation, diagnostics, and life sciences solutions. Founded in 1937 by Richard Perkin and Charles Elmer, the company developed from optical instrument manufacturing into a provider of laboratory consumables, analytical platforms, and clinical diagnostic systems. Its customer base spans pharmaceutical companies, academic institutions, hospitals, and government agencies, with operations across North America, Europe, Asia, and Latin America.

History

PerkinElmer traces roots to the 1930s when founders Richard Perkin and Charles Elmer began crafting optical instruments in New York, contemporaneous with firms like Zeiss and Leica Camera AG. During World War II the company, similar to General Electric and Westinghouse Electric Corporation, expanded into defense and aerospace optics, supplying components used by Boeing and Lockheed Martin. In the postwar decades PerkinElmer pivoted toward analytical chemistry and clinical diagnostics alongside peers such as Thermo Fisher Scientific and Agilent Technologies. Strategic moves in the 1980s and 1990s, mirroring consolidation trends seen with Siemens and Roche, saw acquisitions and divestitures that broadened offerings into molecular spectroscopy and immunoassay platforms. The early 21st century included major transactions related to environmental monitoring and newborn screening comparable to activities by Abbott Laboratories and Danaher Corporation. Recent corporate reshaping involved splitting, spin-offs, and mergers similar to those executed by Philips and Johnson & Johnson in response to shifting markets in diagnostics and life sciences.

Products and Services

PerkinElmer's portfolio spans analytical instrumentation and diagnostics with product lines competing with Waters Corporation, Shimadzu, and Bruker. Its spectroscopy and chromatography instruments serve laboratories engaged with clients such as Pfizer, Novartis, and GlaxoSmithKline. The company supplies newborn screening platforms used in public health programs alongside technologies from Bio-Rad Laboratories and Siemens Healthineers. In genomics and cell analysis PerkinElmer offers imaging systems and reagents that align with platforms from Illumina and Becton Dickinson. Environmental monitoring and food safety applications connect PerkinElmer tools to workflows at agencies like United States Environmental Protection Agency and companies such as Nestlé. Consumables and software for laboratory automation place the company in the same market space as Tecan Group and Hamilton Company. Clinical diagnostics instruments and assays are used in hospital networks including Mayo Clinic and Cleveland Clinic.

Corporate Structure and Leadership

PerkinElmer historically organized into business units analogous to divisions at Siemens AG and GE Healthcare: diagnostics, life sciences, environmental solutions, and laboratory services. Its corporate governance features a board of directors with executives overseeing finance, research, and global operations similar to structures at Bristol-Myers Squibb and Eli Lilly and Company. Leadership transitions have involved chief executives and presidents with backgrounds in multinational corporations like Medtronic and Baxter International. Shareholders include institutional investors such as Vanguard Group and BlackRock, Inc., reflecting ownership patterns comparable to other publicly traded healthcare companies like Amgen and AbbVie.

Research, Development, and Acquisitions

R&D efforts at PerkinElmer focus on diagnostics innovation, spectroscopy, imaging, and informatics, paralleling research agendas at Merck & Co. and Sanofi. The company has pursued acquisitions to expand capabilities in genomics, prenatal testing, and laboratory services similar to transactions by Hologic and Qiagen. Collaborative research programs have linked PerkinElmer with universities such as Harvard University, Massachusetts Institute of Technology, and Stanford University and with contract research organizations like IQVIA and PPD. Patents and proprietary technologies developed by the company intersect with intellectual property portfolios seen at Roche Diagnostics and Agilent Technologies. Strategic divestitures and spin-offs echoed moves by Philips Healthcare and Thermo Fisher Scientific as market focus shifted toward high-growth diagnostics and life-science markets.

Market Presence and Financial Performance

PerkinElmer maintains a global footprint with operations in markets served by multinational corporations like Siemens Healthineers and Abbott Laboratories. Revenue streams derive from instrument sales, consumables, software, and service contracts, resembling business models at Becton Dickinson and Waters Corporation. The company is publicly listed, with stock performance analyzed by financial institutions such as Goldman Sachs and Morgan Stanley and monitored by exchanges like the New York Stock Exchange and indices including the S&P 500 (at various times depending on index inclusion). Market segmentation includes pharmaceuticals, biotechnology, clinical laboratories, and government agencies, aligning PerkinElmer with competitors like Thermo Fisher Scientific and Agilent Technologies for contract bids and procurement.

Regulatory Compliance and Controversies

Operating in regulated sectors, PerkinElmer engages with agencies including the U.S. Food and Drug Administration, European Medicines Agency, and various national public health bodies, similar to compliance landscapes navigated by Roche and Abbott. FDA approvals and CE markings have been central to product commercialization in diagnostics and medical devices, comparable to processes faced by Hologic and Siemens Healthineers. The company has encountered regulatory reviews and public scrutiny over product claims, environmental reporting, and manufacturing quality in episodes reminiscent of controversies involving Johnson & Johnson and Bayer. Litigation and settlement matters have involved product liability and contract disputes akin to cases among Medtronic and GE Healthcare. PerkinElmer’s engagements with public health programs and government contracts place it in the same oversight frameworks as Quest Diagnostics and LabCorp.

Category:Companies based in Massachusetts